• search
For Quick Alerts
ALLOW NOTIFICATIONS  
For Daily Alerts

Indian-origin expert explains failure of first inhaled insulin product

By Super Admin
|

Washington, September 24 (ANI): An Indian-origin expert at the University of Colorado Denver has shed light on why an inhaled insulin product turned out to be a commercial failure.

Dr. Satish K. Garg, a professor of Medicine and Pediatrics at the University of Colorado Denver, says that the results of a 2-year Phase 3 trial conducted in 385 patients suggest that AIR inhaled insulin was inferior to SC insulin in its ability to maintain optimal blood glucose levels over time, based on measurements of glycosylated hemoglobin (HbA1c).

Similarly, another study on 500 patients with type 1 diabetes showed inferiority of AIR in a 6-month trial.

"The question now remains whether this route of delivering insulin has been exhausted or if it still remains to be explored," writes Dr. Satish Garg, who is also the Editor-in-Chief of Diabetes Technology and Therapeutics, and William Kelly, from the University of Colorado Denver.

An editorial titled 'Insulin Delivery via Lungs-Is It Still Possible?' says that a company called MannKind Corporation has recently filed a New Drug Application with the Food and Drug Administration (FDA) for Technosphere Insulin.

It offers faster onset of action with lower postprandial blood glucose excursions especially in the first two hours and is weight neutral, according to the Editorial. (ANI)

For Daily Alerts
Get Instant News Updates
Enable
x
Notification Settings X
Time Settings
Done
Clear Notification X
Do you want to clear all the notifications from your inbox?
Settings X
We use cookies to ensure that we give you the best experience on our website. This includes cookies from third party social media websites and ad networks. Such third party cookies may track your use on Oneindia sites for better rendering. Our partners use cookies to ensure we show you advertising that is relevant to you. If you continue without changing your settings, we'll assume that you are happy to receive all cookies on Oneindia website. However, you can change your cookie settings at any time. Learn more